Ielpo Benedetto, Caruso Riccardo, Ferri Valentina, Quijano Yolanda, Duran Hipolito, Diaz Eduardo, Fabra Isabel, Oliva Catalina, Olivares Sergio, Plaza José Carlos, Vicente Emilio
Hepatogastroenterology. 2013 Nov-Dec;60(128):2069-75.
BACKGROUND/AIMS: The majority of the time extended liver resections cannot be realized because of an insufficient future remnant liver. Baumgart suggests recently combining liver partition and portal vein section for staged hepatectomy, named ALPPS procedure. Our aim is to share our initial experience with ALPPS procedure and to perform the first comprehensive English literature review.
From January 2011 until June 2013, 6 patients underwent ALPPS, performing 6 extended right hepatectomies (one with concomitant right colectomy, one with main biliary duct resection).
The present series showed a mean of 110% volume hypertrophy of the future remnant liver achieved with a mean of 15.3 days after ALPPS. One patient experienced severe liver failure, one had biliary leak and one died for postoperative respiratory distress syndrome. After a mean followup of 16.2 months (range 2-30 months) one patient had liver recurrence. In an English literature search, we identified 18 publications describing a mean hypertrophy rate of 85%, a mean morbidity and mortality rate of 35% and 6%, respectively.
ALPPS is an effective technique used to induce an increased and rapid growth of the future remnant liver, but at the price of a higher morbidity and mortality compared with other conventional procedures.
背景/目的:由于未来剩余肝脏不足,大多数情况下无法进行扩大肝切除术。鲍姆加特最近建议将肝分割与门静脉离断术相结合进行分期肝切除术,即ALPPS手术。我们的目的是分享我们在ALPPS手术方面的初步经验,并进行首次全面的英文文献综述。
从2011年1月至2013年6月,6例患者接受了ALPPS手术,实施了6例扩大右半肝切除术(1例同时行右半结肠切除术,1例同时行主胆管切除术)。
本系列研究显示,ALPPS术后平均15.3天,未来剩余肝脏平均体积肥大110%。1例患者发生严重肝衰竭,1例发生胆漏,1例因术后呼吸窘迫综合征死亡。平均随访16.2个月(范围2 - 30个月)后,1例患者出现肝复发。在英文文献检索中,我们发现18篇出版物描述的平均肥大率为85%,平均发病率和死亡率分别为35%和6%。
ALPPS是一种用于促使未来剩余肝脏快速增大的有效技术,但与其他传统手术相比,其代价是更高的发病率和死亡率。